TOKYO, Japan – Health officials in Tokyo, Japan are closely monitoring a concerning situation as nearly 1,000 cases of a deadly bacterial infection have been reported throughout the country. Streptococcal Toxic Shock Syndrome (STSS), also known as ‘flesh-eating bacteria’, has been rapidly spreading and resulting in fatalities within a short timeframe.
According to the National Institute of Infectious Diseases, the number of STSS cases has risen to 977 by June 2 this year, surpassing last year’s total of 941 cases. This severe bacterial infection is caused by group A Streptococcus bacteria, which can infiltrate deep tissues and the bloodstream, releasing toxins that induce a dangerous reaction in the body, according to the Centers for Disease Control and Prevention (CDC).
Initial symptoms of STSS include fever, chills, muscle aches, nausea, and vomiting, progressing within 24 to 48 hours to low blood pressure, organ failure, rapid heart rate, and fast breathing. While Group A Streptococcus typically causes strep throat in children, it can lead to more severe symptoms in adults such as limb pain, swelling, fever, and low blood pressure, potentially escalating to tissue death, breathing difficulties, organ failure, and even death, especially in individuals over the age of 50.
Preventing STSS entails practicing good hygiene habits like regular handwashing, covering the mouth during coughing and sneezing, and ensuring proper wound care with prompt medical attention for any signs of infection. Early medical intervention is crucial in treating severe symptoms and preventing complications that could arise from the infection.
Diagnosing STSS involves a series of tests including blood tests to detect group A strep bacteria and evaluate organ function. Treatment generally involves administering potent antibiotics through an IV to eradicate the bacteria, along with providing fluids to stabilize blood pressure and support organ function. In severe cases, surgical intervention may be necessary to remove infected tissue and prevent further health issues, emphasizing the importance of swift treatment to enhance recovery chances and reduce the risk of complications or death related to STSS.









Lord Abbett High Yield Fund Q4 2025 Commentary: What Investors Need to Know for a Profitable Future!
Jersey City, New Jersey—In the closing quarters of 2025, Lord Abbett High Yield Fund navigated a challenging investment landscape, marked by evolving interest rates and shifting economic indicators. Analysts noted that despite initial obstacles, investors were encouraged by the fund’s strategic allocation and management decisions, which positioned it favorably amidst market uncertainty. The fund’s performance during the fourth quarter reflected a cautious but calculated approach to high-yield debt. With inflationary pressures beginning to stabilize, the fund’s managers focused on identifying opportunities in sectors that showed ... Read more